Stocktoria
Esperion Therapeutics, Inc. ESPR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2013-06-24
Esperion Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 13,983,662 | $31.0M |
| TWO SIGMA INVESTMENTS, LP | 9,458,779 | $25.9M |
| D. E. Shaw & Co., Inc. | 6,540,785 | $17.9M |
| Point72 Asset Management, L.P. | 1,689,372 | $4.6M |
| RENAISSANCE TECHNOLOGIES LLC | 1,620,100 | $4.4M |
| CITADEL ADVISORS LLC | 946,010 | $2.6M |
| MILLENNIUM MANAGEMENT LLC | 604,345 | $1.7M |
| AQR CAPITAL MANAGEMENT LLC | 314,866 | $862,733 |
Source: SEC EDGAR filings · CIK 0001434868 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.